Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Eli Muchtar, Angela Dispenzieri(WinnMed), Francis K. Buadi, Morie A. Gertz(Mayo Clinic in Arizona), Nelson Leung(Memorial Sloan Kettering Cancer Center), Robert A. Kyle(Mayo Clinic in Arizona), Shaji Kumar(Mayo Clinic in Arizona), Ronald S. Go(Mayo Clinic), Prashant Kapoor, Amie Fonder, Yi L. Hwa, Stephen J. Russell(Mayo Clinic), Steven R. Zeldenrust, Rahma Warsame, S. Vincent Rajkumar(Mayo Clinic), Wilson I. Gonsalves(Mayo Clinic), Martha Grogan(Boston University), Taxiarchis Kourelis, Martha Q. Lacy, Yi Lin, Suzanne R. Hayman, John A. Lust, Miriam Hobbs, David Dingli
Cited by 340
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k